Avalo Therapeutics (C6K0) Ownership - Who Owns Avalo Therapeutics?
0 Followers
Avalo Therapeutics (C6K0) Ownership Overview
- 0.70% Insiders
- 20.02% Mutual Funds
- 0.48% Other Institutional Investors
- 13.40% ETFs
- 65.40% Public Companies and Individual Investors
The ownership structure of Avalo Therapeutics (DE:C6K0) stock is a mix of institutional, retail, and individual investors. Approximately 33.90% of the company’s stock is owned by Institutional Investors, 0.70% is owned by Insiders, and 65.40% is owned by Public Companies and Individual Investors.
The ownership structure of Avalo Therapeutics (DE:C6K0) stock is a mix of institutional, retail, and individual investors. Approximately 33.90% of the company’s stock is owned by Institutional Investors, 0.70% is owned by Insiders, and 65.40% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 18, 2026 | Christopher Ryan Sullivan | $696,927 | |
| Aug 11, 2026 | Jennifer Riley | $52,011 | |
| Mar 17, 2026 | Doyle Mittie | $411,441 | |
| Nov 16, 2025 | Jonathan Goldman | $162,876 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | €945,064 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 4,365,553 | Institution | 8.14% | 31,108,931 |
| Vanguard | 2,557,785 | Institution | 4.77% | 18,226,776 |
| Andrew J.M. Spokes | 2,498,000 | Institution | 4.66% | 17,800,748 |
| Vanguard Index Funds | 2,212,739 | Institution | 4.13% | 15,767,978 |
| Ishares | 2,054,059 | Institution | 3.83% | 14,637,224 |
| Spdr | 1,784,989 | Institution | 3.33% | 12,719,832 |
| Fidelity Concord Street Trust | 1,475,681 | Institution | 2.75% | 10,515,703 |
| Fidelity Capital Trust | 1,211,600 | Institution | 2.26% | 8,633,862 |
| Peter Kolchinsky | 1,000,000 | Institution | 1.86% | 7,126,000 |
| Fidelity Securities Fund | 695,600 | Institution | 1.30% | 4,956,846 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,212,739 | Institution | 4.13% | 15,767,978 |
| Fidelity Concord Street Trust | 1,475,681 | Institution | 2.75% | 10,515,703 |
| Fidelity Capital Trust | 1,211,600 | Institution | 2.26% | 8,633,862 |
| Fidelity Securities Fund | 695,600 | Institution | 1.30% | 4,956,846 |
| Fidelity Advisor Series Vii | 639,700 | Institution | 1.19% | 4,558,502 |
| Fidelity Rutland Square Trust Ii | 586,000 | Institution | 1.09% | 4,175,836 |
| Fidelity Salem Street Trust | 506,015 | Institution | 0.94% | 3,605,863 |
| Ab Cap Fund, Inc. | 486,556 | Institution | 0.91% | 3,467,198 |
| T. Rowe Price Health Sciences Fund, Inc. | 471,822 | Institution | 0.88% | 3,362,204 |
| Columbia Funds Series Trust I | 424,953 | Institution | 0.79% | 3,028,215 |
FAQ
Who Owns Avalo Therapeutics (DE:C6K0)?
According to the latest TipRanks data, approximately 33.90% of the company's stock is held by institutional investors, 0.70% is held by insiders, and 65.40% is held by public companies and individual investors.
What percentage of Avalo Therapeutics (DE:C6K0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 33.90% of Avalo Therapeutics (DE:C6K0) stock is held by institutional investors: 20.02% by mutual funds, 13.40% by ETFs and 0.48% by other institutional investors.
What percentage of Avalo Therapeutics (DE:C6K0) stock is held by retail investors?
According to the latest TipRanks data, approximately 65.40% of Avalo Therapeutics (DE:C6K0) stock is held by public companies and individual investors.
Who owns the most shares of Avalo Therapeutics (DE:C6K0)?
BlackRock, Inc. owns the most shares of Avalo Therapeutics (DE:C6K0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
